BioMarin Pharmaceutical Inc.
NasdaqGS:BMRN
$ 96.92
$-0.87 (-0.89%)
$ 96.92
$-0.87 (-0.89%)
End-of-day quote: 11/25/2022

BMRN - BioMarin Pharmaceutical Stock Prediction 2025 - 2030

20 years of reliable BioMarin Pharmaceutical stock forecast. The Wall Street analysts predict Outperform for BMRN. See at a glance whether NasdaqGS:BMRN will rise in the future.

$208.30
Forecast 2022
$767.87
Forecast 2025
$2263.53
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2022
$208.30
Forecast 2025
$767.87
Forecast 2030
$2263.53
TopGraphs Quality Ranking
Underperform

BioMarin Pharmaceutical Stock Forecast 2022

$111.00

In the last five quarters, BioMarin Pharmaceutical’s Price Target has risen from $109.05 to $113.64 - a 4.21% increase. Nine analysts predict that BioMarin Pharmaceutical’s share price will fall in the coming year, reaching $111.00. This would represent a decrease of -2.32%.

14.53%
14.53

Highest Price Target $162.00

Average Price Target $111.00

Lowest Price Target $74.00

BioMarin Pharmaceutical Stock Predictions 2025

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jan 2025.

In January 2025, analysts believe the stock price will be $618.41. An increase of 538.06% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Feb 2025.

In February 2025, analysts believe the stock price will be $631.99. An increase of 552.08% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Mar 2025.

In March 2025, analysts believe the stock price will be $645.58. An increase of 566.1% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Apr 2025.

In April 2025, analysts believe the stock price will be $659.17. An increase of 580.12% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in May 2025.

In May 2025, analysts believe the stock price will be $672.76. An increase of 594.14% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jun 2025.

In June 2025, analysts believe the stock price will be $686.34. An increase of 608.16% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Jul 2025.

In July 2025, analysts believe the stock price will be $699.93. An increase of 622.18% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Aug 2025.

In August 2025, analysts believe the stock price will be $713.52. An increase of 636.19% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Sep 2025.

In September 2025, analysts believe the stock price will be $727.11. An increase of 650.21% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Oct 2025.

In October 2025, analysts believe the stock price will be $740.69. An increase of 664.23% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Nov 2025.

In November 2025, analysts believe the stock price will be $754.28. An increase of 678.25% compared to the previous month's estimate.

Stock Forecast for the Price of an BioMarin Pharmaceutical Share in Dec 2025.

In December 2025, analysts believe the stock price will be $767.87. An increase of 692.27% compared to the previous month's estimate.

BioMarin Pharmaceutical Stock Prediction 2030

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jan 2030.

In Jan 2030 analysts predict a share price of $1937.88. An increase of 1899.46% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Feb 2030.

In Feb 2030 analysts predict a share price of $1967.48. An increase of 1,930% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Mar 2030.

In Mar 2030 analysts predict a share price of $1997.09. An increase of 1960.55% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Apr 2030.

In Apr 2030 analysts predict a share price of $2026.69. An increase of 1991.1% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in May 2030.

In May 2030 analysts predict a share price of $2056.29. An increase of 2021.64% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jun 2030.

In Jun 2030 analysts predict a share price of $2085.90. An increase of 2052.19% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Jul 2030.

In Jul 2030 analysts predict a share price of $2115.50. An increase of 2082.73% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Aug 2030.

In Aug 2030 analysts predict a share price of $2145.11. An increase of 2113.28% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Sep 2030.

In Sep 2030 analysts predict a share price of $2174.71. An increase of 2143.82% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Oct 2030.

In Oct 2030 analysts predict a share price of $2204.32. An increase of 2174.37% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Nov 2030.

In Nov 2030 analysts predict a share price of $2233.92. An increase of 2204.91% compared to today's share price.

Stock Prediction for the Price of One BioMarin Pharmaceutical Share in Dec 2030.

In Dec 2030 analysts predict a share price of $2263.53. An increase of 2235.46% compared to today's share price.

Company Info

P/E Ratio
108.1
Beta
0.34
Price-to-book Ratio
3.94
Market Cap
18.01B
TEV
16.072 B
LT Debt/Cap
0.02%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
114.92%
Forecast 2Y
342.28%
Analyst Price Target
$113.64

About BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.

BioMarin Pharmaceutical Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
108.1
Beta
0.34
Price-to-book Ratio
3.94
Market Cap
18.01B
TEV
16.072 B
LT Debt/Cap
0.02%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
114.92%
Forecast 2Y
342.28%
Analyst Price Target
$113.64

Financials

Year Year 2020 2021
Rev. Revenue
1860.46 1846.28
GM % Gross Margin %
38.1 74.5
OI Operating Income
-91.76 -74.32
OM Operating Margin
-4.93 -4.03
NI Net Income
859.10 -64.08
EPS % Earnings Per Share %
1.63 1.33
Div. Dividends
0.00 0.00
PR % Payout Ratio %
0 0
Sha. Shares
182 184
OCF Operating Cash Flow
85 305
CS Cap Spending
-114 -114
FCF Free Cash Flow
-29 190
FCFS Free Cash Flow Per Share
0.08 1.01

BioMarin Pharmaceutical Analyst Ratings Frequently Asked Questions

Who are the analysts watching BioMarin Pharmaceutical Inc.?

The following analysts have recently covered BioMarin Pharmaceutical:

Baird
Barclays
BofA Global Research
Canaccord Genuity
CFRA Equity Research
Citigroup Inc
Cowen and Company
Credit Suisse
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Jefferies LLC
Marktfeld
Morgan Stanley
Morningstar Inc.
Oppenheimer & Co. Inc.
Piper Sandler Companies
RBC Capital Markets
Stifel
Truist Securities
Wedbush Securities Inc.
William Blair & Company L.L.C.
SVB Securities LLC
Cantor Fitzgerald & Co.
Baptista Research
Probes Reporter LLC
(This information refers to the last 90 days.)

Who are the sell-side analysts watching BioMarin Pharmaceutical Inc.?

The following sell-side analysts have recently covered BioMarin Pharmaceutical:

Beatty, Joel Lawrence
Wang, Huidong
Meacham, Geoffrey Christopher
Gilson, Michelle Lim
Glickman, Stewart
Bansal, Mohit
Nadeau, Philip M.
Fauth, Tiago Felipe
Schimmer, Joshua Elliott
Richter, Salveen Jaswal
Chattopadhyay, Debjit D.
Tewari, Akash
Paraskevopoulos, Michail
Harrison, Matthew Kelsey
Andersen, Karen
Gershell, Leland James
Raymond, Christopher Joseph
Matteis, Paul Andrew
Schwartz, Joseph Patrick
Karnauskas, Robyn Kay Shelton
Lugo, Timothy Francis
Issi, Luca
Argyrides, Andreas
Brayer, Olivia Simone
Majumdar, Ishan
Fye, Jessica Macomber
Gavin, John P.
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy